Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
25.14 USD | -3.16% | +5.10% | +218.63% |
05-31 | Jasper Therapeutics, Inc. to Present Data on Briquilimab in Mast Cell Driven Diseases at the EAACI Congress 2024 | CI |
05-20 | Transcript : Jasper Therapeutics, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+218.63% | 379M | |
+42.60% | 748B | |
+32.98% | 598B | |
-5.74% | 356B | |
+17.79% | 325B | |
+3.37% | 283B | |
+16.94% | 245B | |
+8.79% | 211B | |
-4.38% | 209B | |
+6.74% | 165B |
- Stock Market
- Equities
- JSPR Stock
- News Jasper Therapeutics, Inc.
- Jasper Therapeutics : Oppenheimer Starts Jasper Therapeutics at Outperform with $21 Price Target